Gemphire Therapeutics Receives $2,650,000 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bc61c660-7747-4df7-820c-1ef71c28b54b
Date
12/23/2015
Company Name
Gemphire Therapeutics
Mailing Address
43334 Seven Mile Road Northville, MI 48167 USA
Company Description
Our mission is to develop novel drugs, such as gemcabene, to treat the large, growing unmet need of dyslipidemia patients who are unable to reach optimal LDL cholesterol or triglyceride levels with statin or other therapies.
Website
http://www.gemphire.com
Transaction Type
Debt
Transaction Amount
$2,650,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. 52 investors participated in the original and amended offering. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing – amended.
M&A Terms
Venture Investor
Undisclosed